Coeptis Therapeutics Holdings, Inc. Warrants (COEPW) Stock Price

COEPWStock
$0.00
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta-0.78

COEPW Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-72.44%
Price vs S&P 500 (4W)-28.04%
VGM Score44.47

Industry Peers — Finance Services(179)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/E Ratio (Annual)ROE (TTM)Operating Margin (TTM)Revenue Growth (5Y)Price
COEPWCoeptis Therapeutics Holdings, Inc. Warrants
——C————$0.00
AXPAmerican Express CompanyDBB19.5x34.1%18.2%16.0%$313.59
NUNu Holdings Ltd.DBB24.5x30.3%22.7%84.5%$14.56
MSTRStrategy Inc Common Stock Class ADDB—-60.8%-7272.5%-0.1%$136.83
COINCoinbase Global, Inc. Class A Common StockDCB36.2x-6.9%9.9%41.2%$173.16
SYFSYNCHRONY FINANCIALBCB6.7x20.9%18.4%0.9%$73.68
CRCLCircle Internet Group, Inc.DCB126.1x13.6%7.4%—$82.22
SOFISoFi Technologies, Inc. Common StockDBC39.0x6.2%-19.9%—$14.55
BMNRBitMine Immersion Technologies, Inc.DAB37.5x-84.6%-14505.1%428.4%$21.66
CHYMChime Financial, Inc. Class A Common StockDAA—-1.3%-2.1%—$29.67
IRENIREN Limited Ordinary SharesDBD183.7x-23.0%-163.9%145.7%$26.99

About Coeptis Therapeutics Holdings, Inc. Warrants

Coeptis Therapeutics is a biopharmaceutical company developing cell therapies for CD38-related cancers. The company's pipeline includes multi-antigen CAR T technology (SNAP-CAR) licensed from the University of Pittsburgh, a CD38-targeting natural killer cell therapy (CD38-GEAR-NK), and companion diagnostics developed with VyGen-Bio and the Karolinska Institutet.